Kim HJ - Search Results

1

Multigenerational analysis of reproductive timing and life cycle parameters in the marine rotifer Brachionus plicatilis.

Hong MS, Kim JS, Jin YR, Kim HJ, Lee JS, Lee MC. Hong MS, et al. Among authors: kim hj, kim js. Mar Pollut Bull. 2024 Dec;209(Pt B):117196. doi: 10.1016/j.marpolbul.2024.117196. Epub 2024 Nov 6. Mar Pollut Bull. 2024. PMID: 39509907

2

Involvement of CYP3A4 and MDR1 in altered metabolism and transport of indinavir in 1,25(OH)₂D₃-treated Caco-2 cells.

Lee SJ, Joo SA, Kim H, Lee Y, Chung SJ, Chae YJ, Maeng HJ. Lee SJ, et al. Among authors: kim h. Eur J Pharm Sci. 2023 Apr 1;183:106396. doi: 10.1016/j.ejps.2023.106396. Epub 2023 Jan 31. Eur J Pharm Sci. 2023. PMID: 36736464 Free article.

3

Synthetic Peucedanocoumarin IV Prevents α-Synuclein Neurotoxicity in an Animal Model of Parkinson's Disease.

Kim H, Maeng HJ, Kim JH, Yoon JH, Oh Y, Paek SM, Lee Y. Kim H, et al. Among authors: kim jh. Int J Mol Sci. 2022 Aug 3;23(15):8618. doi: 10.3390/ijms23158618. Int J Mol Sci. 2022. PMID: 35955753 Free PMC article.

4

ATF4-activated parkin induction contributes to deferasirox-mediated cytoprotection in Parkinson's disease.

Ham S, Kim JH, Kim H, Shin JY, Lee Y. Ham S, et al. Toxicol Res. 2022 Dec 8;39(2):191-199. doi: 10.1007/s43188-022-00157-x. eCollection 2023 Apr. Toxicol Res. 2022. PMID: 37008698 Free PMC article.

5

AIMP2 accumulation in brain leads to cognitive deficits and blood secretion in Parkinson's disease.

Kim H, Shin JY, Ham S, Kim JH, Lee GH, Lee NE, Kim HT, Cho SH, Kim S, Lee Y. Kim H, et al. J Transl Med. 2024 Oct 10;22(1):919. doi: 10.1186/s12967-024-05666-x. J Transl Med. 2024. PMID: 39390613 Free PMC article.

6

Pharmacological inhibition of AIMP2 aggregation attenuates α-synuclein aggregation and toxicity in Parkinson's disease.

Shin JY, Lee B, Ham S, Kim JH, Kim H, Kim H, Jo MG, Kim HJ, Park SW, Kweon HS, Kim YJ, Yun SP, Lee Y. Shin JY, et al. Among authors: kim h, kim yj, kim hj, kim jh. Biomed Pharmacother. 2022 Dec;156:113908. doi: 10.1016/j.biopha.2022.113908. Epub 2022 Oct 22. Biomed Pharmacother. 2022. PMID: 36283223 Free article.

7

Therapeutic Evaluation of Synthetic Peucedanocoumarin III in an Animal Model of Parkinson's Disease.

Ham S, Kim H, Yoon JH, Kim H, Song BR, Choi JY, Lee YS, Paek SM, Maeng HJ, Lee Y. Ham S, et al. Among authors: kim h. Int J Mol Sci. 2019 Nov 4;20(21):5481. doi: 10.3390/ijms20215481. Int J Mol Sci. 2019. PMID: 31689937 Free PMC article.

8

Amyloid-like oligomerization of AIMP2 contributes to α-synuclein interaction and Lewy-like inclusion.

Ham S, Yun SP, Kim H, Kim D, Seo BA, Kim H, Shin JY, Dar MA, Lee GH, Lee YI, Kim D, Kim S, Kweon HS, Shin JH, Ko HS, Lee Y. Ham S, et al. Sci Transl Med. 2020 Nov 11;12(569):eaax0091. doi: 10.1126/scitranslmed.aax0091. Sci Transl Med. 2020. PMID: 33177178 Free PMC article.

9

HDAC4/5 Inhibitor, LMK-235 Improves Animal Voluntary Movement in MPTP-Induced Parkinson's Disease Model.

Lee H, Kim HJ, Min JS, Lee E, Choi DK, Choi JH, Seo Y, Lee S, Im CY, Bae GH, Oh Y, Ko EA, Jung SC, Kim SH, Kwon OB. Lee H, et al. Among authors: kim hj. Pharmacol Res Perspect. 2025 Feb;13(1):e70057. doi: 10.1002/prp2.70057. Pharmacol Res Perspect. 2025. PMID: 39806528

10

Single-cell transcriptomics in a child with coenzyme Q10 nephropathy: potential of single-cell RNA sequencing in pediatric kidney disease.

Park PG, Choi S, Ahn YH, Kim SH, Kim C, Kim HJ, Kang HG. Park PG, et al. Among authors: kim hj. Pediatr Nephrol. 2025 Jan 14. doi: 10.1007/s00467-024-06611-2. Online ahead of print. Pediatr Nephrol. 2025. PMID: 39805995

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21,895 results

Search Page

Filters